Cara Therapeutics, Inc. (CARA)
NASDAQ: CARA · Real-Time Price · USD
0.423
+0.014 (3.35%)
At close: Dec 20, 2024, 4:00 PM
0.425
+0.002 (0.57%)
After-hours: Dec 20, 2024, 7:26 PM EST
Cara Therapeutics Market Cap
Cara Therapeutics has a market cap or net worth of $23.18 million as of December 20, 2024. Its market cap has decreased by -64.55% in one year.
Market Cap
23.18M
Enterprise Value
25.15M
1-Year Change
-64.55%
Ranking
Category
Stock Price
$0.42
Market Cap Chart
Since January 31, 2014, Cara Therapeutics's market cap has decreased from $282.00M to $23.18M, a decrease of -91.78%. That is a compound annual growth rate of -20.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 23.20M | -42.72% |
| Dec 29, 2023 | 40.50M | -92.98% |
| Dec 30, 2022 | 577.10M | -11.37% |
| Dec 31, 2021 | 651.10M | -13.65% |
| Dec 31, 2020 | 754.00M | 0.27% |
| Dec 31, 2019 | 752.00M | 46.65% |
| Dec 31, 2018 | 512.80M | 28.49% |
| Dec 29, 2017 | 399.10M | 57.44% |
| Dec 30, 2016 | 253.50M | -44.78% |
| Dec 31, 2015 | 459.10M | 102.16% |
| Dec 31, 2014 | 227.10M | -19.47% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Longeveron | 23.74M |
| NeuroOne Medical Technologies | 23.38M |
| Alterity Therapeutics | 23.31M |
| Co-Diagnostics | 23.16M |
| Vivos Therapeutics | 22.53M |
| iBio, Inc. | 22.14M |
| Allurion Technologies | 22.08M |
| GeoVax Labs | 21.89M |